TruAlt Bioenergy Ltd Q1 FY27 Earnings Analysis

- TruAlt Bioenergy aims to achieve sales of at least 40 crore litres of ethanol, with a bonus target of 55 crore litres in FY 2027. - Current ethanol sales are around 2.2 crore litres per month, with production capacity of 6 crore litres; expected to rise to about 5 crore litres per month once additional 15 crore litres orders are implemented. - Revenue run rate potentially exceeds INR 450 crores per three months, targeting INR 700 crores with the implementation of new orders. - Diversification is underway: exploring sustainable aviation fuel (about 25-30% of gross ethanol capacity), export opportunities, and CBG business growth. - CBG business targets INR 400 crores annual revenue with 50-60% EBITDA margin, planning phased expansion beyond 10+4 plants. - Retail fuel vertical expansion: currently seven retail outlets generating INR 105 crores revenue, targeting up to 75 outlets, indicating strong revenue growth. - Overall, growth is tied to policy implementation timelines, court order enforcement, and policy clarity beyond 2025.

- TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres, enhancing revenue potential. - The company plans to diversify revenue through sustainable aviation fuel, export of ethanol, Compressed Biogas (CBG) expansion, and fuel retail outlets, creating multiple growth avenues. - CBG business shows promising margins (~50-60% EBITDA) with ongoing plant commissioning and plans for phased scale-up beyond the initial 14 plants. - Ethanol segment benefits from production-linked incentive (PLI) and interest subvention schemes, improving profitability. - Retail fuel outlets are poised to grow from 7 to about 75 outlets, significantly increasing revenue contributions. - Plant commissioning timelines (e.g., new plant in 24-30 months by FY29) will progressively contribute once operational. - Management is proactive in optimizing operations and marketing to drive top-line and margin improvements. - Overall, earnings and margins are expected to improve steadily with capacity ramp-up, diversification, and government policy support.

- TruAlt Bioenergy plans significant capex in commissioning new plants, including commissioning one ethanol plant with a 24-30 months timeline, targeting FY29 for operation. - Investment in CBG plants: 9-10 plants expected live this year and another 10-15 in the pipeline. Funding is planned via 70% debt and 30% equity, with the company investing 51% and JV partners Sumitomo and GAIL contributing 49%. - Capital infusion for CBG subsidiaries is already provisioned and partly tied up with NABARD loans at favorable rates (~8.65%). - Expansion of fuel retail vertical: targeting to operate 75 fuel retail outlets in the near future, currently seven operational generating INR105 crores revenue. - Strategic focus on alternative uses such as sustainable aviation fuel and ethanol exports to diversify revenue streams and reduce reliance on government policy. - Continuing investments in integrated multi-feed ethanol plants and capacity expansion from existing units.

- TruAlt Bioenergy plans to fund their upcoming CBG plants through a mix of debt and equity. - The company will invest 51% equity, while joint venture partners Sumitomo and GAIL will contribute 49%. - Capital for subsidiaries has already been provisioned and infused. - Funding for Sumitomo plants is tied up with NABARD at an interest rate of 8.65%. - Leafiniti Bioenergy has several sanctions for debt funding at rates lower than NABARD’s. - The target debt-to-equity mix for CBG projects is approximately 70:30. - No explicit mention of new equity fundraising in the current call, but management intends to increase investor interactions going forward.

- The company has a current orderbook comprising around 40 crore litres allocated to public and private OMCs (Oil Marketing Companies), including 8 crore litres from private OMCs. - There is an additional court-ordered allocation of 15 crore litres that has not yet been executed by the OMCs due to a pending related legal matter. - Pending orders include approximately 6.2 crore litres from private OMCs where lifting has not started despite purchase orders and indents issued. - Total targeted volume for FY 2027 is around 55 crore litres (40 crore litres current + 15 crore litres court-ordered quantity). - Delay in implementation of the 15 crore litres allocation results in an inventory buildup of around INR500 crores. - The company expects the pending 15 crore litres order to be lifted by September 2026, post resolution of the related legal case.